NIH-funded research Fellowship grant

Understanding how TCF4 mutations affect brain cell development in autism.

Official title: Investigating the effects of TCF4 mutations during oligodendrocyte development and maturation in a human-derived model of autism spectrum disorder

Funded at Lieber Institute, INC. · NIH-10996523 · Data updated 2026-11-12

This study is looking at how changes in a specific gene can affect important brain cells that help with nerve insulation, which could help us understand Pitt-Hopkins Syndrome better and find new treatments for it.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionLieber Institute, INC.
NIH-funded
Lab location1 site (Baltimore, United States)
Project startDecember 12, 2024
Project endDecember 11, 2027
Funding year2024
Award (this year)$74,284
NIH project number1F32MH135665-01A1
Project IDNIH-10996523 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Pitt-Hopkins Syndrome or those with TCF4 mutations associated with autism spectrum disorder.

Less likely to help

Patients without TCF4 mutations or those not diagnosed with autism spectrum disorder may not benefit from this research.

What this research studies

This research investigates the impact of mutations in the TCF4 gene on the development and maturation of oligodendrocytes, which are crucial brain cells involved in myelination. Using patient-derived induced pluripotent stem cells (iPSCs), the study aims to replicate the effects of these mutations in a human model, allowing for a better understanding of how they contribute to conditions like Pitt-Hopkins Syndrome, a rare form of autism spectrum disorder. The research employs both two-dimensional and three-dimensional protocols to differentiate these stem cells into oligodendrocytes, with the goal of identifying potential therapeutic targets for drug screening.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve brain function and quality of life for individuals with Pitt-Hopkins Syndrome and related conditions.

How similar studies have gone: Previous research using animal models has shown promising results in understanding TCF4 mutations, but this approach in human-derived models is relatively novel.

Where this research is happening

  • Lieber Institute, INC.
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Romero Morales, Alejandra Ines — Lieber Institute, INC.
  • Study coordinator: Romero Morales, Alejandra Ines

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.